Novartis | 销售成本

Cost Of Sales 更改 日
AbbVie USD 4.09B 181M 2024-03
Amgen USD 3.2B 88M 2024-03
AstraZeneca USD 2.22B 63M 2024-03
Bausch Health Companies USD 640M 65M 2024-03
Biogen USD 542.2M 76.1M 2024-03
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Canopy Growth CAD 57.32M 7.04M 2024-03
Catalent USD 845M 8M 2024-03
Corcept Therapeutics USD 2.53M 658K 2024-03
Drreddys Laboratories INR 29.94B 1.51B 2023-12
Eli Lilly USD 1.67B 114.5M 2024-03
Gilead Sciences USD 1.55B 59M 2024-03
GlaxoSmithKline GBP 1.97B 363M 2024-03
Glaxosmithkline GBP 1.97B 363M 2024-03
J&J USD 6.51B 287M 2024-03
Merck USD 3.54B 200M 2024-03
Novartis USD 3.1B 109M 2024-03
Novartis USD 3.1B 109M 2024-03
Pacira USD 47.42M 276K 2024-03
Perrigo USD 724.4M 5.2M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Prestige Brands USD 125.17M 371K 2024-03
Roche Holding CHF 7.62B 1.33B 2023-06
Sanofi EUR 3.44B 402M 2024-03
Sanofi EUR 3.44B 402M 2024-03
Supernus Pharmaceuticals USD 16.31M 3.32M 2024-03
Zoetis USD 643M 83M 2024-03



Novartis 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.